Member Biographical Information
Muhamed Baljevic, MD
Focusing on plasma cell dyscrasias, more specifically, PI resistance in MM. Opening a phase I/II study of c-MET inhibitor as a rational way to salvage PI resistance in rrMM. Interested to develop new treatment strategies for rrMM. Planning to study molecular signatures of various dyscrasia overlaps.